<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The WHO classification published in 2001 defined a new category of <z:e sem="disease" ids="C0018939" disease_type="Disease or Syndrome" abbrv="">hematological disease</z:e>, myelodysplastic/<z:mpath ids='MPATH_512'>myeloproliferative diseases</z:mpath> (<z:e sem="disease" ids="C1301355" disease_type="Neoplastic Process" abbrv="">MDS/MPD</z:e>), that have both <z:hpo ids='HP_0002863'>myelodysplasia</z:hpo> and myeloproliferation at the time of initial presentation </plain></SENT>
<SENT sid="1" pm="."><plain>This category consists of four subclasses, <z:hpo ids='HP_0011010'>chronic</z:hpo> myelomonocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e>), atypical <z:mp ids='MP_0005481'>CML</z:mp>(aCML), juvenile <z:hpo ids='HP_0005506'>chronic myelogenous leukemia</z:hpo> and <z:e sem="disease" ids="C1301355" disease_type="Neoplastic Process" abbrv="">MDS/MPD</z:e>-unclassifiable (<z:e sem="disease" ids="C1301355" disease_type="Neoplastic Process" abbrv="">MDS/MPD</z:e>-u) </plain></SENT>
<SENT sid="2" pm="."><plain>In order to clarify the clinical features of these diseases, we analyzed clinical data of tentatively diagnosed <z:e sem="disease" ids="C1301355" disease_type="Neoplastic Process" abbrv="">MDS/MPD</z:e> cases in the past ten years accumulated from affiliated hospitals </plain></SENT>
<SENT sid="3" pm="."><plain>By reviewing the data of each case according to the criteria, we diagnosed 31 cases of <z:e sem="disease" ids="C1301355" disease_type="Neoplastic Process" abbrv="">MDS/MPD</z:e>, including 22 cases of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e>, 5 cases of aCML and 4 cases of <z:e sem="disease" ids="C1301355" disease_type="Neoplastic Process" abbrv="">MDS/MPD</z:e>-u </plain></SENT>
<SENT sid="4" pm="."><plain>Male predominance and high age were common among these three subclasses </plain></SENT>
<SENT sid="5" pm="."><plain>The prognosis of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e> was poor compared to other subclasses because of the high incidence of <z:e sem="disease" ids="C0005699" disease_type="Neoplastic Process" abbrv="">blast crisis</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>It is noteworthy that <z:e sem="disease" ids="C0005699" disease_type="Neoplastic Process" abbrv="">blast crisis</z:e> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e> exclusively occurred within one year after diagnosis </plain></SENT>
<SENT sid="7" pm="."><plain>Young age, a high percentage of blasts in the peripheral blood, <z:hpo ids='HP_0001744'>splenomegaly</z:hpo>, <z:hpo ids='HP_0002716'>lymphadenopathy</z:hpo> and clonal cytogenetic abnormality were associated with <z:e sem="disease" ids="C0005699" disease_type="Neoplastic Process" abbrv="">blast crisis</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>It is suggested that there are two subgroups in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e> which differ in disease progression </plain></SENT>
<SENT sid="9" pm="."><plain>Thus, these indicators may be useful in deciding the therapeutic strategy including hematopoietic cell transplantation for the high risk subgroup </plain></SENT>
<SENT sid="10" pm="."><plain>There were four <z:e sem="disease" ids="C1301355" disease_type="Neoplastic Process" abbrv="">MDS/MPD</z:e> cases with a history of preceding <z:e sem="disease" ids="C0018939" disease_type="Disease or Syndrome" abbrv="">hematological diseases</z:e>, such as <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> or malignant <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>Among these, three cases with a long-term history of treatment with metenolone <z:chebi fb="49" ids="30089,47622">acetate</z:chebi> developed <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e> </plain></SENT>
<SENT sid="12" pm="."><plain>It is suggested that the long-term effect of <z:chebi fb="3" ids="50113">androgen</z:chebi> plays a role in the pathophysiology of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e> </plain></SENT>
</text></document>